Neuro Dawn
Latest round
- Series C
Last raised
- Nov 2024
Total raised
- $11M
Investors
- 8
About Neuro Dawn
Established in 2020 and based in Nanjing, China, Neuro Dawn is a biopharmaceutical company that focuses on the research and development of central nervous system (CNS) drugs. The company mainly involved in the field of cognitive impairment, affective disorder, neuropathic pain, and cerebrovascular disease. Besides, it established small molecular new drugs R&D platforms and production bases. The company's pipeline includes the Y-1 project for Alzheimer's disease drugs, the Y-2 project for stroke drugs, the Y-3 project for stroke and post-stroke depression, the Y-4 project for neuropathic pain drugs, the Y-5 project for cerebral small blood vessels disease, Y-6 project for post-stroke repair and Y-8 project for treatment of ALS (amyotrophic lateral sclerosis) and spinal cord injury. And the Y-2 project has entered into clinical phase 3, the Y1 project, the Y3 project, and the Y6 project have entered into clinical phase 2, and other new drug projects will enter into clinical phase 1. Those drugs use the technologies of sublingual drug delivery formulation and multi-target drug development. The company’s revenue is generated by providing drugs for central nervous system diseases.
Who invested in Neuro Dawn
8 investors across 4 rounds
See all investors in Neuro Dawn
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Neuro Dawn
Who invested in Neuro Dawn?
Neuro Dawn has 8 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Neuro Dawn raised?
Neuro Dawn has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Neuro Dawn last raise money?
Neuro Dawn's most recent round on record is a Series C, in Nov 2024.
What does Neuro Dawn do?
Established in 2020 and based in Nanjing, China, Neuro Dawn is a biopharmaceutical company that focuses on the research and development of central nervous system (CNS) drugs.
Where is Neuro Dawn headquartered?
Neuro Dawn is headquartered in Nanjing, China.
Which VCs invest in companies like Neuro Dawn?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Neuro Dawn's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Neuro Dawn? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.